[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0400495T3 - N-phenylalkyl-substituerede alfa-aminocarboxamidderivater samt fremgangsmåde til fremstilling deraf - Google Patents

N-phenylalkyl-substituerede alfa-aminocarboxamidderivater samt fremgangsmåde til fremstilling deraf

Info

Publication number
DK0400495T3
DK0400495T3 DK90109950.7T DK90109950T DK0400495T3 DK 0400495 T3 DK0400495 T3 DK 0400495T3 DK 90109950 T DK90109950 T DK 90109950T DK 0400495 T3 DK0400495 T3 DK 0400495T3
Authority
DK
Denmark
Prior art keywords
phenylalkyl
preparation
substituted alpha
alkyl
derivatives
Prior art date
Application number
DK90109950.7T
Other languages
English (en)
Inventor
Philippe Dostert
Paolo Pevarello
Franco Heidempergher
Mario Varasi
Alberto Bonsignori
Romeo Roncucci
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898912071A external-priority patent/GB8912071D0/en
Priority claimed from GB909007567A external-priority patent/GB9007567D0/en
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Application granted granted Critical
Publication of DK0400495T3 publication Critical patent/DK0400495T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/02—Monothiocarboxylic acids
    • C07C327/04—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/06—Monothiocarboxylic acids having carbon atoms of thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90109950.7T 1989-05-25 1990-05-25 N-phenylalkyl-substituerede alfa-aminocarboxamidderivater samt fremgangsmåde til fremstilling deraf DK0400495T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898912071A GB8912071D0 (en) 1989-05-25 1989-05-25 N-phenylalkyl substituted-alpha-amino carboxamide derivatives and process for their preparation
GB909007567A GB9007567D0 (en) 1990-04-04 1990-04-04 New n-substituted alpha-amino carboxamide derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
DK0400495T3 true DK0400495T3 (da) 1993-12-06

Family

ID=26295400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90109950.7T DK0400495T3 (da) 1989-05-25 1990-05-25 N-phenylalkyl-substituerede alfa-aminocarboxamidderivater samt fremgangsmåde til fremstilling deraf

Country Status (23)

Country Link
US (3) US5236957A (da)
EP (2) EP0400495B1 (da)
JP (1) JP2771328B2 (da)
KR (1) KR0179661B1 (da)
CN (1) CN1027588C (da)
AT (1) ATE96775T1 (da)
AU (1) AU645752B2 (da)
CA (1) CA2033190C (da)
CZ (1) CZ281420B6 (da)
DE (1) DE69004337T2 (da)
DK (1) DK0400495T3 (da)
ES (1) ES2062174T3 (da)
FI (1) FI114792B (da)
HU (2) HUT55348A (da)
IE (1) IE63934B1 (da)
IL (1) IL94466A (da)
MY (1) MY105618A (da)
NO (1) NO179944C (da)
NZ (1) NZ233785A (da)
PT (1) PT94160B (da)
RU (1) RU2097371C1 (da)
WO (1) WO1990014334A1 (da)
YU (1) YU48322B (da)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
WO1994026303A1 (en) * 1993-05-13 1994-11-24 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
CN1114106A (zh) * 1993-08-30 1995-12-27 大制药株式会社 苄胺衍生物
US5741818A (en) 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
JP2001526648A (ja) * 1997-04-22 2001-12-18 コセンシス・インコーポレイテッド 炭素環及びヘテロ環で置換されたセミカルバゾン及びチオセミカルバゾン、及びその使用
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
JP2001517689A (ja) * 1997-10-01 2001-10-09 フレミントン ファーマシューティカル コーポレイション 極性または非極性の、バッカルスプレーまたはカプセル
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
IL136044A (en) 1997-11-21 2005-08-31 Euro Celtique Sa 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
GB9727523D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
ATE303162T1 (de) * 1999-04-09 2005-09-15 Euro Celtique Sa Natrium kanalblocker zusammensetzungen und deren verwendung
DE10049822B4 (de) * 1999-11-03 2005-12-22 Siemens Ag Verfahren zur Darstellung eines Untersuchungsobjektes unter Verwendung von Schnittbildern
US6306911B1 (en) * 2000-02-07 2001-10-23 Ortho-Mcneil Pharmaceutical, Inc. Substituted amino acids as neutral sphingomyelinase inhibitors
ES2253579T3 (es) * 2001-09-03 2006-06-01 Newron Pharmaceuticals S.P.A. Composicion farmaceutica que comprende gabapentina o un analogo suyo y una alfa-aminoamida y su uso analgesico.
US6667327B2 (en) 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
US20040213842A1 (en) 2003-01-30 2004-10-28 Dynogen Pharmaceuticals, Inc. Methods of treating gastrointestinal tract disorders using sodium channel modulators
AR044007A1 (es) 2003-04-11 2005-08-24 Newron Pharmaceuticals Inc Metodos para el tratamiento de la enfermedad de parkinson
US6979750B1 (en) 2003-04-18 2005-12-27 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US7321065B2 (en) 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
EP1658062B1 (en) * 2003-08-25 2010-02-17 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as anti-inflammatory agents
EP1524265A1 (en) * 2003-10-15 2005-04-20 Newron Pharmaceuticals S.p.A. Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors
BRPI0415842A (pt) 2003-10-23 2007-01-02 Hoffmann La Roche derivativos de benzapepina como inibidores de mao-b
EP1557166A1 (en) 2004-01-21 2005-07-27 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
EP1588704A1 (en) * 2004-04-22 2005-10-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
WO2006001463A1 (ja) 2004-06-23 2006-01-05 Ono Pharmaceutical Co., Ltd. Ｓ１ｐ受容体結合能を有する化合物およびその用途
RS51411B (en) * 2004-09-10 2011-02-28 Newron Pharmaceuticals S.P.A. USE (R) - (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDE AS SELECTIVE MODULATORS OF SODIUM AND / OR CALCIUM CHANNELS
TW200730494A (en) 2005-10-10 2007-08-16 Glaxo Group Ltd Novel compounds
TW200728258A (en) 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
ATE472529T1 (de) * 2005-10-10 2010-07-15 Glaxo Group Ltd Prolinamidderivate als natriumkanalmodulatoren
BRPI0620239B8 (pt) 2005-12-22 2021-05-25 Newron Pharm Spa derivados de 2-feniletilamino.
EP1870097A1 (en) * 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
EP2474521B1 (en) 2006-06-19 2016-08-10 Newron Pharmaceuticals S.p.A. High purity degree 2-[4-(3- and 2-fluorobenzyloxy)benzylamino]propanamides for use as medicaments and pharmaceutical formulations containing them
CN101495185A (zh) * 2006-07-28 2009-07-29 爱尔康研究有限公司 用于治疗外层视网膜病症的单胺氧化酶抑制剂
KR100868353B1 (ko) * 2007-03-08 2008-11-12 한국화학연구원 도파민 ｄ4 수용체 길항제인 신규 피페라지닐프로필피라졸유도체, 이의 제조방법 및 이를 포함하는 약학적 조성물
GB0706630D0 (en) * 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds
LT2155663T (lt) 2007-06-15 2018-02-12 Newron Pharmaceuticals S.P.A. Pakeisti 2-[2-(fenil)etilamino]alkanamidų dariniai ir jų, kaip natrio ir (arba) kalcio kanalų moduliatorių, panaudojimas
CN104523668B (zh) * 2007-12-11 2020-06-09 纽朗制药有限公司 高纯度的2-[4-(3-或2-氟苄氧基)苄氨基]丙酰胺类及其用途
EP2222290B1 (en) 2007-12-19 2021-06-16 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives for the treatment of psychiatric disorders
US9212155B2 (en) * 2008-03-19 2015-12-15 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
AU2009225647C1 (en) 2008-03-19 2015-11-19 Aurimmed Pharma, Inc. Novel compounds advantageous in the treatment of central nervous system diseases and disorders
US10793515B2 (en) 2008-03-19 2020-10-06 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
EP2314569A1 (en) 2009-10-22 2011-04-27 Merck Patent GmbH Novel polymorphic forms of (S)-2-[4-(3-Fluoro-benzyloxy)-benzylamino]-propionamide mesylate salt and processes of manufacturing thereof
BR112012027623B1 (pt) 2010-04-27 2021-07-06 Newron Pharmaceuticals S.P.A. Processo para a produção de sais de ralfinamida metanossulfonato ou seus renantiômeros, forma pseudopolimorfa de hemi-hidrato cristalino h do sal de metanossulfonato de ralfinamida, ou seu r-enantiômero, seu uso e formulação farmacêutica que o compreende
KR101679568B1 (ko) 2014-10-02 2016-11-28 한국과학기술연구원 알파-아미노아미드 유도체 화합물 및 이를 포함하는 약학적 조성물
ES2774800T3 (es) 2014-10-02 2020-07-22 Megabiowood Co Ltd Compuesto derivado de alfa-aminoamida y composición farmacéutica que contiene el mismo
WO2016102967A1 (en) 2014-12-23 2016-06-30 Convergence Pharmaceuticals Limited Process for preparing alpha-carboxamide pyrrolidine derivatives
JP2018521021A (ja) 2015-06-11 2018-08-02 バジリア・ファルマスーチカ・インターナショナル・アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ａｇ 排出ポンプ阻害剤及びその治療的使用
CN105061245A (zh) * 2015-08-25 2015-11-18 成都维恒医药科技有限公司 一种高纯度沙芬酰胺的制备方法
SG11202002706XA (en) 2017-10-05 2020-04-29 Biogen Inc Process for preparing alpha-carboxamide pyrolidine derivatives
EP3762364B1 (en) 2018-03-08 2023-08-23 Sunshine Lake Pharma Co., Ltd. Pyrrolidineamide derivatives and uses thereof
WO2019205147A1 (zh) * 2018-04-28 2019-10-31 上海璃道医药科技有限公司 包含苯并含氧脂肪环结构的氨基乙酰胺类化合物及其用途
CN108997163A (zh) * 2018-07-18 2018-12-14 华东理工大学 含苯并脂肪环结构的氨基乙酰胺类化合物及其用途
US11111208B2 (en) 2019-06-17 2021-09-07 RK Pharma Solutions LLC Process for the preparation of safinamide mesylate intermediate
US11225457B2 (en) 2019-08-06 2022-01-18 Medichem, S.A. Process for preparing safinamide
CN110938014A (zh) * 2019-11-28 2020-03-31 岳千奥 取代苯氧酰胺衍生物、应用及用于治疗帕金森病的药物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) * 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US4049663A (en) * 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
US4311853A (en) * 1979-02-06 1982-01-19 The Radiochemical Centre Limited Selenium derivatives of thyroxine and tri-iodothyronine
DE3050800C2 (da) * 1979-03-22 1989-06-22 Continental Pharma Inc., Bruessel/Bruxelles, Be
US4267354A (en) * 1979-04-25 1981-05-12 E. R. Squibb & Sons, Inc. Substituted amides having antiinflammatory activity and intermediates
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
GB8409015D0 (en) * 1984-04-06 1984-05-16 Eschem Ltd Binding
DE3416693A1 (de) * 1984-05-05 1985-11-07 Bayer Ag, 5090 Leverkusen Verfahren zur behandlung von cellulosischen fasermaterialien
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4715619A (en) * 1986-01-13 1987-12-29 Printmark, Inc. Book jacket
GB8714901D0 (en) * 1986-07-23 1987-07-29 Ici Plc Amide derivatives

Also Published As

Publication number Publication date
KR0179661B1 (ko) 1999-05-15
JP2771328B2 (ja) 1998-07-02
AU645752B2 (en) 1994-01-27
YU48322B (sh) 1998-05-15
HU211550A9 (en) 1995-12-28
NO179944C (no) 1997-01-15
CA2033190A1 (en) 1990-11-26
CN1027588C (zh) 1995-02-08
IL94466A (en) 1995-01-24
EP0400495A1 (en) 1990-12-05
US5391577A (en) 1995-02-21
NZ233785A (en) 1992-12-23
IE63934B1 (en) 1995-06-28
IE901878L (en) 1990-11-25
MY105618A (en) 1994-11-30
US5502079A (en) 1996-03-26
EP0400495B1 (en) 1993-11-03
FI910354A0 (fi) 1991-01-23
CN1047496A (zh) 1990-12-05
ES2062174T3 (es) 1994-12-16
JPH04500215A (ja) 1992-01-16
HU905133D0 (en) 1991-04-29
EP0426816A1 (en) 1991-05-15
PT94160A (pt) 1991-01-08
CA2033190C (en) 2003-04-08
CZ252090A3 (en) 1996-06-12
YU102290A (sh) 1992-07-20
NO179944B (no) 1996-10-07
DE69004337D1 (de) 1993-12-09
AU5729990A (en) 1990-12-18
NO910270D0 (no) 1991-01-23
ATE96775T1 (de) 1993-11-15
WO1990014334A1 (en) 1990-11-29
RU2097371C1 (ru) 1997-11-27
PT94160B (pt) 1997-04-30
DE69004337T2 (de) 1994-02-24
CZ281420B6 (cs) 1996-09-11
IL94466A0 (en) 1991-03-10
HUT55348A (en) 1991-05-28
FI114792B (fi) 2004-12-31
KR920701131A (ko) 1992-08-11
US5236957A (en) 1993-08-17
NO910270L (no) 1991-01-23

Similar Documents

Publication Publication Date Title
DK0400495T3 (da) N-phenylalkyl-substituerede alfa-aminocarboxamidderivater samt fremgangsmåde til fremstilling deraf
DE69827785D1 (de) 1,4-substituierte cyclische aminderivate
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
ATE219766T1 (de) N-acylierte 4-aminopiperidin derivate als aktive bestandteile von peripher gefässerweiternden wikstoffen
ES2113355T3 (es) Derivados de amidas ciclicas.
FI924932A (fi) Aromatiska amidinderivat och salter daerav samt deras framstaellning
ATE404539T1 (de) Kondensierte pyridinderivate
PT628311E (pt) Derivado de xantina com actividade antidepressiva
HUP0002682A1 (hu) VLA-4 által közvetített leukocita adhéziót gátló dipeptidszármazékok
DE69613240D1 (de) N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden
ATE173256T1 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
DK0662471T3 (da) Naphthalenderivater med affinitet over for melatonin-receptorer, fremgangsmåde til deres fremstilling og farmaceutiske samm
FR2653017A1 (fr) Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
TW333532B (en) Benzopyrans
EP0647446A4 (en) NEW MEDICAL USE OF A DIHYDROPYRIDINE DERIVATIVE.
DE68910090D1 (de) Verwendung heterozyklischer Amide zur Verhinderung der Tumormetastasierung.
TW357140B (en) Substituted benzenesulfonylureas and -thioureas having cardiac activity, processes for their preparation, and the pharmaceutical compositions thereof
ES2058835T3 (es) Derivados de tioformamida.
MX9603735A (es) Compuestos fungicidas.